Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function
Clinical trial NCT01896297 · COMPLETED
Trial details
- NCT number
- NCT01896297
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2015-10-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.